STOCK TITAN
  1. Home
  2. Sec-filings
  3. TACT
  4. [Form 4/A] TRANSACT TECHNOLOGIES INC Amended Insider Trading Activity

TransAct Technologies (TACT) corrects director RSU grant to 15,759

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4/A

Rhea-AI Filing Summary

TransAct Technologies filed an amended Form 4 to correct a director equity award. On February 24, 2026, Daniel M. Friedberg received a grant of 15,759 Restricted Stock Units under the 2014 Equity Incentive Plan, rather than the 14,700 units previously reported.

The RSUs cliff vest on the first anniversary of the grant and convert into common stock on a one-for-one basis. 325 Capital LLC is entitled to the economic interest in securities granted for Mr. Friedberg’s board service, and multiple affiliated entities may be deemed to share beneficial ownership, which they each disclaim except for any pecuniary interest.

Positive

  • None.

Negative

  • None.
Insider 325 CAPITAL LLC, FRIEDBERG DANIEL M., Shrivastava Anil K, 325 Capital Master Fund LP, 325 Capital GP, LLC
Role Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner
Type Security Shares Price Value
Grant/Award Restricted Stock Units 15,759 $0.00 --
Holdings After Transaction: Restricted Stock Units — 15,759 shares (Indirect, See Footnotes)
Footnotes (1)
  1. On February 26, 2026, the Reporting Persons (as defined below) filed a Form 4 (the "Original Form 4") which inadvertently reported an incorrect number of Restricted Stock Units granted February 24, 2026. The Original Form 4 reported a grant of 14,700 Restricted Stock Units, and this amendment is being filed to report the correct number of Restricted Stock Units granted as 15,759. Restricted Stock Units issued on February 24, 2026 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, cliff vesting on the first anniversary date of the grant and converting to common stock on a one-for-one basis. This Report is filed jointly by 325 Capital LLC, a Delaware limited liability company ("325"), 325 Capital Master Fund LP, a Cayman Islands exempted limited partnership ("325 Master Fund"), 325 Capital GP, LLC, a Delaware limited liability company registered as a foreign partnership in the Cayman Islands ("325 Capital GP"), Michael D. Braner, a citizen of the United States of America, Daniel M. Friedberg, a citizen of the United States of America, and Anil K. Shrivastava, a citizen of the United States of America (collectively, the "Reporting Persons"), each of whom may be deemed to have a pecuniary interest in the securities reported on this Form 4. These securities are owned directly by Daniel M. Friedberg, a Managing Member of 325 who serves on the board of directors of TransAct Technologies Incorporated (the "Company"). 325 is entitled to receive all of the economic interest in securities granted to Mr. Friedberg in respect of Mr. Friedberg's service on the board of directors, and may therefore be deemed to beneficially own these securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended. 325 Capital GP is the general partner of 325 Master Fund, 325 is the investment manager to 325 Master Fund, and each of Messrs. Braner, Friedberg and Shrivastava are Managing Members of 325. As a result, all of the Reporting Persons may be deemed to beneficially own the securities owned directly by Mr. Friedberg. The other Reporting Persons may also be deemed "directors by deputization" of the Company. Each of the Reporting Persons disclaims any beneficial ownership of any of these securities, except to the extent of any pecuniary interest therein.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
325 CAPITAL LLC
(Last) (First) (Middle)
757 THIRD AVENUE
20TH FLOOR
(Street)
NEW YORK NY 10017
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
TRANSACT TECHNOLOGIES INC [ TACT ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
02/26/2026 		6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units(1) (2) 02/24/2026 A 15,759 (2) (2) Common Stock 15,759 $0(2) 15,759 I(3)(4)(5) See Footnotes(3)(4)(5)
1. Name and Address of Reporting Person*
325 CAPITAL LLC
(Last) (First) (Middle)
757 THIRD AVENUE
20TH FLOOR
(Street)
NEW YORK NY 10017
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
FRIEDBERG DANIEL M.
(Last) (First) (Middle)
757 THIRD AVENUE
20TH FLOOR
(Street)
NEW YORK NY 10017
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Shrivastava Anil K
(Last) (First) (Middle)
757 THIRD AVENUE
20TH FLOOR
(Street)
NEW YORK NY 10017
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
325 Capital Master Fund LP
(Last) (First) (Middle)
190 ELGIN AVENUE
GEORGE TOWN
(Street)
GRAND CAYMAN E9 KY1-9008
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
325 Capital GP, LLC
(Last) (First) (Middle)
757 THIRD AVENUE
20TH FLOOR
(Street)
NEW YORK NY 10017
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. On February 26, 2026, the Reporting Persons (as defined below) filed a Form 4 (the "Original Form 4") which inadvertently reported an incorrect number of Restricted Stock Units granted February 24, 2026. The Original Form 4 reported a grant of 14,700 Restricted Stock Units, and this amendment is being filed to report the correct number of Restricted Stock Units granted as 15,759.
2. Restricted Stock Units issued on February 24, 2026 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, cliff vesting on the first anniversary date of the grant and converting to common stock on a one-for-one basis.
3. This Report is filed jointly by 325 Capital LLC, a Delaware limited liability company ("325"), 325 Capital Master Fund LP, a Cayman Islands exempted limited partnership ("325 Master Fund"), 325 Capital GP, LLC, a Delaware limited liability company registered as a foreign partnership in the Cayman Islands ("325 Capital GP"), Michael D. Braner, a citizen of the United States of America, Daniel M. Friedberg, a citizen of the United States of America, and Anil K. Shrivastava, a citizen of the United States of America (collectively, the "Reporting Persons"), each of whom may be deemed to have a pecuniary interest in the securities reported on this Form 4.
4. These securities are owned directly by Daniel M. Friedberg, a Managing Member of 325 who serves on the board of directors of TransAct Technologies Incorporated (the "Company"). 325 is entitled to receive all of the economic interest in securities granted to Mr. Friedberg in respect of Mr. Friedberg's service on the board of directors, and may therefore be deemed to beneficially own these securities for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended. 325 Capital GP is the general partner of 325 Master Fund, 325 is the investment manager to 325 Master Fund, and each of Messrs. Braner, Friedberg and Shrivastava are Managing Members of 325. As a result, all of the Reporting Persons may be deemed to beneficially own the securities owned directly by Mr. Friedberg. The other Reporting Persons may also be deemed "directors by deputization" of the Company.
5. Each of the Reporting Persons disclaims any beneficial ownership of any of these securities, except to the extent of any pecuniary interest therein.
/s/ William J. DeFrances, Attorney-in-fact for 325 CAPITAL LLC 03/13/2026
/s/ William J. DeFrances, Attorney-in-fact for FRIEDBERG DANIEL M. 03/13/2026
/s/ William J. DeFrances, Attorney-in-fact for Shrivastava Anil K. 03/13/2026
/s/ William J. DeFrances, Attorney-in-fact for 325 CAPITAL MASTER FUND LP 03/13/2026
/s/ William J. DeFrances, Attorney-in-fact for 325 CAPITAL GP, LLC 03/13/2026
/s/ William J. DeFrances, Attorney-in-fact for Braner Michael David 03/13/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did TransAct Technologies (TACT) report in this Form 4/A?

TransAct Technologies reported a corrected grant of 15,759 Restricted Stock Units to director Daniel M. Friedberg. These units were issued as equity compensation and replace a previously misstated figure of 14,700 units in the original Form 4 filing.

Why did TransAct Technologies (TACT) file an amended Form 4/A?

The company filed an amended Form 4/A to fix an error in the number of Restricted Stock Units granted on February 24, 2026. The original report showed 14,700 units, but the correct amount of director RSUs granted was 15,759.

How do the 15,759 Restricted Stock Units for TACT’s director vest and convert?

The 15,759 Restricted Stock Units granted to director Daniel M. Friedberg cliff vest on the first anniversary of the February 24, 2026 grant date. Once vested, they convert into an equal number of TransAct Technologies common shares on a one-for-one basis.

Who is considered to have a pecuniary interest in the TACT RSU grant?

The filing states that 325 Capital LLC, 325 Capital Master Fund LP, 325 Capital GP, LLC, and Messrs. Braner, Friedberg, and Shrivastava may be deemed to have a pecuniary interest in the RSUs, though each disclaims beneficial ownership beyond any economic interest.

Does this TACT Form 4/A disclose any open-market stock purchases or sales?

No open-market purchases or sales are disclosed. The filing reports a grant of 15,759 Restricted Stock Units as equity compensation, classified as an acquisition under transaction code "A," with no buy or sell transactions indicated in the transaction summary.